160 likes | 361 Views
By Jobin S. Kalathil. Sleep Aids. Sleep Orders of Interest:. Insomnia : is characterized by the inability to fall asleep and/or remain asleep for a reasonable amount of time. Restless legs syndrome (RLS): is characterized by an irresistible urge to move legs while sleeping.
E N D
By Jobin S. Kalathil Sleep Aids
Sleep Orders of Interest: Insomnia: is characterized by the inability to fall asleep and/or remain asleep for a reasonable amount of time. Restless legs syndrome (RLS): is characterized by an irresistible urge to move legs while sleeping. Bed wetting: is associated with the involuntary passing of urine while asleep; after the age at which bladder control would normally be anticipated.
General Principles of Treatment: Treatments for sleep disorders can be grouped into three general categories: 1) behavioral/ psychotherapeutic treatments 2) medications 3) other somatic treatments (like surgery)
Insomnia The three types of insomnia are: 1) Transient insomnia 2) Acute Insomnia 3) Chronic Insomnia
Medications: The most commonly used drugs are: Benzodiazepines Commonly prescribed benzodiazepines include: temazepam, diazepam, lorazepam, flurazepam, nitrazepam and midazolam http://www.etfrc.com/benzos1.htm
Non-benzodiazepine prescription drugs Ambien Lunesta
Selectively binds to the melatonin receptors instead of GABA receptors. Rozerem
Restless Leg Syndrome Requip http://www.neurosci.pharm.utoledo.edu/MBC3320/images/Ropinirole.gif
Bed wetting Two main types of drugs prescribed: Tricyclic antidepressant prescription drugs (e.g. Amitriptyline, Imipramine or Nortriptyline)
Bed wetting • Desmopressin
Works Cited "Cognitive Behavior Therapy and Pharmacotherapy for Insomnia." Archives of Internal Medicine 164. 16 Mar. 2007 <http://archinte.amaassn.org/cgi/content/abstract/164/17/1888>. Griffiths, Rr, M.w Johnson, and P.e Suess. "Ramelteon: a Novel Hypnotic Lacking Abuse Liability and Sedative Adverse Effects." "Mechanism of Action." Requip. 13 Mar. 2007 <http://www.requip.com/pd/hcp/mechanism_of_action.html> Archives of General Psychiatry 63 (2006): 1149-1157. EBSCO. SMU. 12 Mar. 2007. National Institute of Health. Ambien. 12 Mar. 2007 <http://dailymed.nlm.nih.gov/dailymed/fdaDrugXsl.cfm?id=635&type=display>. "New Drug Offers Relief From Chronic Insomnia." Cortlandt Forum 19 (2006): 22. EBSCO. SMU.
"New Evidence That the Pharmacological Effects of Benzodiazepine Receptor Ligands Can Be Associated with Activities At Different BZ (?) Receptor Subtypes." Psychopharmachology. PubMed.Gov. 12 Mar. 2007. Office of Communications and Public Liaison. National Institute of Neurological Disorders and Stroke. Restless Legs Syndrome Fact Sheet. 14 Feb. 2007. 12 Mar. 2007 <http://www.ninds.nih.gov/disorders/restless_legs/detail_restless_legs.htm#84783237>. "PRAMIPEXOLE/ROPINIROLE." National Institute of Neurological Disorders and Stroke. 11 Mar. 2007 <http://www.ninds.nih.gov/funding/research/parkinsonsweb/drug_summaries/pramipexole.htm>. "Requip." GlaxoSmithKline. 11 Mar. 2007 <http://us.gsk.com/products/assets/us_requip.pdf>.
"REQUIP." http://www.requip.com/. GlaxoSmithKline. 15 Mar. 2007 <http://us.gsk.com/products/assets/us_requip.pdf>. "Restless Legs Syndrome." Wikepedia. 14 Mar. 2007 <http://en.wikipedia.org/wiki/Restless_legs_syndrome>. "Rozerem." Wikipedia. 10 Mar. 2007 <http://en.wikipedia.org/wiki/Rozerem>. "Sleep Disorders." Wikipedia. 9 Mar. 2007 <http://en.wikipedia.org/wiki/Sleep_disorder>.